Madison Avenue Partners, LP

Madison Avenue Partners, LP is an investment firm based in New York City, specializing in opportunistic, value-oriented investments. The firm manages assets for a diverse group of partners, including leading university endowments, hospital systems, and philanthropic foundations. With a long-term orientation and a flexible, global mandate, Madison Avenue Partners focuses on identifying mispriced securities across various sectors and geographies.

The firm's investment strategy encompasses a range of stages, including growth, late stage, pre-IPO, and buyout opportunities. Its asset class focus spans healthcare, communication services, technology, consumer goods, and financial services. Madison Avenue Partners employs a global long/short equity strategy, targeting both domestic and international markets. The firm is committed to delivering substantial growth and innovation through its investments.

Madison Avenue Partners' portfolio includes investments in companies such as Theravance Biopharma Inc., reflecting its focus on the biopharmaceutical sector. The firm's approach combines deep financial expertise with hands-on, entrepreneurial experience, aiming to create value through strategic planning and active management. Madison Avenue Partners seeks long-term partnerships with its portfolio companies, focusing on sustainable growth and maximizing shareholder value.